Health Care News and Research

RSS

Tolerx establishes Scientific Advisory Board to advance type 1 diabetes study

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, announced today that it has established a Scientific Advisory Board to help advance the company's research and clinical studies in type 1 diabetes.

3 Nov 2010

OncoMed receives $1.2 million to support therapeutic programs under QTDP program

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics that target cancer stem cells, announced today that it has been awarded $1.2 million to support five distinct therapeutic programs under the U.S. Government's Qualifying Therapeutic Discovery Project program.

3 Nov 2010

Neoprobe receives $244,479 grant under QTDP program

Neoprobe Corporation a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has been awarded a grant of $244,479 under the qualifying therapeutic discovery project program established under Section 48D of the Internal Revenue Code.

3 Nov 2010

Working at night and in rotating shifts increase risk of work injury

Canadians who work night and rotating shifts are almost twice as likely to be injured on the job than those working regular day shifts, according to a study by researchers at the University of British Columbia.

3 Nov 2010

BioCryst receives $1.1 million in grants under QTDP program

BioCryst Pharmaceuticals, Inc. today announced that the Company had been awarded $1.1 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the Company's clinical programs for peramivir, BCX4208 and forodesine, as well as the pre-clinical BCX4161 kallikrein inhibitor and JAK inhibitor programs.

3 Nov 2010

Immunomedics product candidates, technologies receive recognition from QTDP program

Immunomedics, Inc. a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that all 12 applications from the Company were certified by the Internal Revenue Service of the Department of Treasury as qualified investments in accordance with the Qualifying Therapeutic Discovery Project (QTDP) program under section 48D of the Internal Revenue Code. As a result, the Company will receive an aggregate cash award of $2.9 million.

3 Nov 2010

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Quanterix Corporation, a single molecule technology company focused on developing a next generation diagnostics platform, announced today that it was awarded a total of $733,437 in grants under the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP program recognized Quanterix's Single Molecule Array (SiMoA™) platform as a promising advance that will improve diagnosis and treatment of disease while reducing healthcare costs.

3 Nov 2010

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

The U.S. is committed to working "closely together to help meet the challenges facing Cambodia and all of Southeast Asia," Secretary of State Hillary Rodham Clinton pledged Monday during a stop in Cambodia as part of her Asia-Pacific tour, that United Press International reports.

3 Nov 2010

Johns Hopkins assists with establishment of Malaysia's first private graduate medical school and teaching hospital

The Johns Hopkins University, the Johns Hopkins University School of Medicine, Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine in Baltimore, USA, and Academic Medical Centre Sdn Bhd, subsidiary of Chase Perdana Sdn Bhd, a Kuala Lumpur-based private development corporation, and an associate company of Turiya Sdn Bhd, have signed an agreement to help Malaysia develop its first fully integrated private four-year graduate medical school and teaching hospital.

3 Nov 2010

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

Enzon Pharmaceuticals, Inc. today announced that it has been awarded $1.2 million in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program, which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010.

3 Nov 2010

IRIN examines MSF'S concerns over U.S. food aid for malnourished children under age 2

IRIN examines the recently launched 1,000 Days campaign and concerns expressed by Medecins Sans Frontieres' (MSF) Emi MacLean that most of the $2 billion the U.S. spends on food aid is for corn soya blend, which lacks animal-source food and is not ideal for children under age 2 or children who are moderately malnourished.

3 Nov 2010

Tests show Haitian cholera strains match ones from South Asia, CDC says

Tests have shown that the strain in Haiti's cholera outbreak is similar to cholera strains found in South Asia, the CDC said on Monday, Agence France-Presse reports (11/1).

3 Nov 2010

Somaxon awarded $245,000 grant for Silenor under QTDP program

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has been awarded a non-taxable grant of approximately $245,000 related to Silenor® (doxepin) under the Qualifying Therapeutic Discovery Project (QTDP) program included in the Patient Protection and Affordable Health Care Act of 2010.

3 Nov 2010

Three states to cast ballots on health insurance mandate; Others consider abortion and marijuana questions

"Voters in three states will cast ballots Tuesday on the new healthcare law's individual mandate to buy insurance," The Hill reports. "Arizona and Oklahoma are expected to pass the state constitutional amendment, but it faces an uphill battle in Colorado. The measure on the ballot in Arizona and Oklahoma is modeled after legislation drafted by the conservative American Legislative Exchange Council.

3 Nov 2010

Staff member of U.S. preventive services task force quits over cancelled meeting

A member of the support staff for the United States Preventive Services Task Force has quit over the cancellation of a meeting scheduled for today and tomorrow at which the task force was due to vote on the controversial issue of prostate-cancer screening.

3 Nov 2010

Brain Research Foundation presents Frederic A. Gibbs Discovery Award to Abbott

The Brain Research Foundation presented the Frederic A. Gibbs Discovery Award to Abbott, a global, broad-based health care company, for its dedication to advancing neuroscience through education, research and philanthropy.

3 Nov 2010

Opinions: Call for African companies to engage in health goals; holistic approach to development

The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses, First Lady of Rwanda Jeannette Kagame and CEO of Access Bank Plc Aigboje Aig-Imoukhuede, who both serve on the Friends of the Global Fund Africa board, write together in a East African opinion piece that calls upon the private sector to help bolster the work with African governments to improve health outcomes in Africa.

3 Nov 2010

Races sometimes hinging on health law issues go down to the wire

Races around the nation are coming down to the wire Tuesday and the controversial health law continues to play a role in the campaign.

3 Nov 2010

Health reform law: Tax credits may boost coverage; rationing still hot word

The number of small businesses offering health insurance to workers is projected to increase sharply this year, recent data show, a shift that researchers attribute to a tax credit in the health law.

3 Nov 2010

Insuring your health: Seniors should consider changes in Medicare Part D plans

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "If you're on Medicare Part D, this month marks the beginning of the annual enrollment time when beneficiaries can try to pick the plan that provides the best coverage for their prescription drugs.

3 Nov 2010

Health Care News and Research

Tolerx establishes Scientific Advisory Board to advance type 1 diabetes study

OncoMed receives $1.2 million to support therapeutic programs under QTDP program

Neoprobe receives $244,479 grant under QTDP program

Working at night and in rotating shifts increase risk of work injury

BioCryst receives $1.1 million in grants under QTDP program

Immunomedics product candidates, technologies receive recognition from QTDP program

Quanterix granted $733,437 under QTDP program for Single Molecule Array platform

Clinton highlights U.S. commitment to strengthening health systems, food security in Cambodia during Asia-Pacific tour

Johns Hopkins assists with establishment of Malaysia's first private graduate medical school and teaching hospital

Enzon receives $1.2 million in funding under IRS Qualifying Therapeutic Discovery Project program

IRIN examines MSF'S concerns over U.S. food aid for malnourished children under age 2

Tests show Haitian cholera strains match ones from South Asia, CDC says

Somaxon awarded $245,000 grant for Silenor under QTDP program

Three states to cast ballots on health insurance mandate; Others consider abortion and marijuana questions

Staff member of U.S. preventive services task force quits over cancelled meeting

Brain Research Foundation presents Frederic A. Gibbs Discovery Award to Abbott

Opinions: Call for African companies to engage in health goals; holistic approach to development

Races sometimes hinging on health law issues go down to the wire

Health reform law: Tax credits may boost coverage; rationing still hot word

Insuring your health: Seniors should consider changes in Medicare Part D plans

Event guide: 3rd Measuring Patient Engagement Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News